Justin Liauw, PharmD, BCOP, precepts PGY2 residents and pharmacy students in adult hematology/oncology experiences. He lectures at the University of Rhode Island and Johnson and Wales University Center on pharmacotherapeutics and is involved in educating medical interns who are rotating on the hematology/oncology service.
Liauw participates in multidisciplinary rounds at both Rhode Island and The Miriam hospitals while providing pharmacy services to hematology/oncology patients. He is also working on updating the credentialing process for pharmacists working in the Comprehensive Cancer Center.
Education: Doctor of Pharmacy, University of Rhode Island (2012)
Residencies: PGY-1 Pharmacy Practice Residency, Maine Medical Center (2013); PGY-2 Oncology Pharmacy Residency, Maine Medical Center (2014)
Practice/Research Interests: Genitourinary Oncology, Gynecologic Oncology, Oncology Supportive Care
Pronouns: He/him
Select Publications:
Liauw J, Brunault R, Quesenverry M, Bakow B. Split- and Reduced-Dose Imatinib in Chronic Myeloid Leukemia: Case Report. J Hematol Oncol Pharm. 2024;14(3):14-17 Sorial M
Huynh J, Azzoli C, Liauw J, Brunault R, Collins C, Zullo A. Survival Outcomes Associated with Corticosteroid Use Before Chemoimmunotherapy in Patients with Advanced Lung Cancer. Eur J Cancer 2021. Mar;145: 234-244
Liauw J, Cabral S. Therapies in the Pipeline for Prostate Cancer. Directions in Oncology Pharmacy 2021 Aug 16, 3(4):17-19